Cargando…
The Evolution of Our Understanding of Immunoproliferative Small Intestinal Disease (IPSID) over Time
Immunoproliferative small intestinal disease (IPSID) is an uncommon disease with a higher prevalence in the developing world. IPSID diagnosis relies mainly on a tissue biopsy and a high index of suspicion. Treatment options are variable; however, they mainly include anthracycline-based chemotherapy...
Autores principales: | AlYamany, Ruah, Kharfan-Dabaja, Mohamed A., Hamadani, Mehdi, Alshaibani, Alfadel, Aljurf, Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139652/ https://www.ncbi.nlm.nih.gov/pubmed/35621691 http://dx.doi.org/10.3390/curroncol29050301 |
Ejemplares similares
-
Treating chronic diarrhea: A systematic review on Immunoproliferative Small Intestinal Disease (IPSID)
por: Evangelista-Leite, Daniele, et al.
Publicado: (2021) -
Draft Genome Sequence of Campylobacter coli Strain IPSID-1 Isolated from a Patient with Immunoproliferative Small Intestinal Disease
por: Criscuolo, Alexis, et al.
Publicado: (2014) -
Clinical, Diagnostic and Prognostic Characteristics of Primary Cutaneous Gamma Delta T-cell Lymphomas
por: Muhsen, Ibrahim N., et al.
Publicado: (2022) -
Lymphocyte Transformation in Immunoproliferative Disorders
por: Catovsky, D., et al.
Publicado: (1972) -
The impact of size and location on rupture of intracranial aneurysms
por: Orz, Yasser, et al.
Publicado: (2015)